Literature DB >> 18453259

Immune properties of mesenchymal stem cells.

Panagiota A Sotiropoulou1, Michael Papamichail.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent progenitor cells isolated by various relatively easily accessible tissues, such as bone marrow and cord blood. MSCs gained attention because of their ease for in vitro expansion together with their multilineage potential. More recently, in vitro and in vivo immunosuppressive properties have been ascribed to them, as they are able to modulate the function of all major immune cell populations, thus impeding immune responses. The underlying mechanisms of their differentiation and function are not thoroughly understood, but still they represent important candidates for tissue regeneration and manipulation of the immune response in graft rejection, graft versus host disease, and autoimmune disorders. Characteristics and immunogenic profile of MSCs, their interface with immune system and their potential use as immunosuppressive elements in cellular therapeutic protocols are reviewed in this chapter.

Entities:  

Mesh:

Year:  2007        PMID: 18453259     DOI: 10.1007/978-1-59745-536-7_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells.

Authors:  Limin Wang; Mark L Weiss; Michael S Detamore
Journal:  Recent Pat Regen Med       Date:  2013

2.  Stem cells to the rescue.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2008-10

3.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

4.  Host stem cells repopulate liver allografts: reverse chimerism.

Authors:  Zhaoli Sun; George Melville Williams
Journal:  Chimerism       Date:  2011 Oct-Dec

5.  Protective effect of berberine against oxidative stress-induced apoptosis in rat bone marrow-derived mesenchymal stem cells.

Authors:  Wangyang Li; Yamei Liu; Bin Wang; Yiwen Luo; Nianhong Hu; Dongfeng Chen; Xunchao Zhang; Yunpu Xiong
Journal:  Exp Ther Med       Date:  2016-11-03       Impact factor: 2.447

6.  Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism.

Authors:  J M Brown; K Nemeth; N M Kushnir-Sukhov; D D Metcalfe; E Mezey
Journal:  Clin Exp Allergy       Date:  2011-01-24       Impact factor: 5.018

7.  Endoplasmic reticulum stress induced by tunicamycin and antagonistic effect of Tiantai No.1 (1) on mesenchymal stem cells.

Authors:  Zheng-zhi Wu; Ying-hong Li; Andrew C J Huang; Ming Li; Xiao-li Zhang; Ji-guo Wang; Min Yang; Man-yin Chen
Journal:  Chin J Integr Med       Date:  2010-02-04       Impact factor: 1.978

Review 8.  Mesenchymal stem cells in treating autism: Novel insights.

Authors:  Dario Siniscalco; James Jeffrey Bradstreet; Nataliia Sych; Nicola Antonucci
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

9.  Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes.

Authors:  V Coppens; Y Heremans; G Leuckx; K Suenens; D Jacobs-Tulleneers-Thevissen; K Verdonck; T Lahoutte; A Luttun; H Heimberg; N De Leu
Journal:  Diabetologia       Date:  2012-10-23       Impact factor: 10.122

Review 10.  Unexpected roles for bone marrow stromal cells (or MSCs): a real promise for cellular, but not replacement, therapy.

Authors:  E Mezey; B Mayer; K Németh
Journal:  Oral Dis       Date:  2009-07-27       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.